Introduction {#sec1}
============

Burns are among the devastating forms of trauma and burn wound infections are the most common complications after burn injury. Multidrug-resistant *Staphylococcus aureus* strains are considered to be one of the common Gram-positive early colonizers of burn wounds [@bib1], [@bib2]. Methicillin, a semisynthetic penicillin, first entered clinical use in 1960 for the treatment of infections caused by β-lactamase--producing staphylococci. However, only 1 year later, *S. aureus* strains that showed resistance to methicillin were reported from clinical infections. Since then, methicillin-resistant *S. aureus* (MRSA) strains have appeared in countries worldwide and continue to be one of the most common pathogens causing healthcare-associated infections (HAIs) [@bib3]. HAIs caused by antibiotic-resistant bacteria are known to be associated with prolonged hospitalization as well as higher healthcare costs and mortality rates in burn patients, and according to a US Centers for Disease Control and Prevention report, 5% of all HAIs are caused by MRSA [@bib4], [@bib5]. The prevalence of MRSA varies from 20% to 90% in Iran [@bib2]. MRSA is usually spread by direct contact with an infected wound or via contaminated hands. Previous studies have shown that about 33% and 2% of people carry *S. aureus* and MRSA in their nares, respectively [@bib6].

MRSA usually carries molecular determinants that confer resistance to a wide range of antibiotics, and treatment of infections caused by these bacteria are challenging [@bib1], [@bib7]. A methicillin-susceptible *S. aureus* (MSSA) strain becomes MRSA by the acquisition of a genetic element called staphylococcal cassette chromosome *mec* (SCC*mec*), carrying the *mecA* gene, regulatory genes, recombinase genes and a variety of accessory genes. Molecular epidemiologic methods for the continuous surveillance of MRSA clones and dissemination of the strains can be used in order to control the infections [@bib8], [@bib9]. Over the past two decades, a variety of methods, such as pulsed-field gel electrophoresis, multilocus enzyme electrophoresis, multilocus sequence typing, accessory gene regulator (*agr*) typing and *spa* typing, have been used for genotypic characterization of MRSA strains and other bacteria [@bib10]. Previous studies in Iran have reported SCCmec type III/to30, t037 as the most common genotypes among MRSA isolates [@bib2]. As common typing methods, pulsed-field gel electrophoresis and multilocus sequence typing are considered to be labor-intensive and expensive; instead, other techniques such as *spa, agr* and SCC*mec* typing methods could be used for reliable and accurate typing of MRSA [@bib11].

In the present study, we used a combination of different techniques including *spa, agr* and SCC*mec* typing to determine the common types of *S. aureus* strains circulating in one burn hospital in Tehran, Iran.

Materials and methods {#sec2}
=====================

Bacterial isolates {#sec2.1}
------------------

A total of 405 clinical and nonclinical samples were obtained from patients (pus and blood), nostrils of HCWs (physicians, nurses and service employees) and inanimate surfaces (Computer mice and keyboards, beds, chairs, medical trolleys, phone receivers, faucet handles, door handles, elevator buttons, toilet flush handles) from different wards (emergency, men, women, children and intensive care unit) in the Shahid Motahari burn hospital in Tehran from 2015 to 2016. Duplicate isolates from the same patient were not included in the study. The isolates were identified to the species level using standard biochemical tests including Gram staining, catalase, tube coagulase and DNase tests as well as mannitol fermentation. All *S. aureus* isolates were confirmed by PCR for the presence of the *nucA* gene [@bib10].

Antimicrobial susceptibility testing {#sec2.2}
------------------------------------

Antibiotic susceptibility testing was performed by using the disc diffusion method and in accordance with the Clinical and Laboratory Standards Institute guidelines for the following antibiotics: nitrofurantoin (300μg), gentamicin (10 μg), mupirocin (20 μg), rifampicin (5 μg), norfloxacin (10 μg), tigecycline (15 μg), ampicillin (10 μg), trimethoprim/sulfamethoxazole (25 μg), chloramphenicol (30 μg), erythromycin (15 μg), clindamycin (2 μg), tetracycline (30 μg), penicillin (10 U), linezolid (30 μg), quinupristin/dalfopristin (15 μg) and imipenem (10 μg) (Mast, Merseyside, UK). Screening for the MRSA isolates was performed using cefoxitin (30 μg) discs on Müller-Hinton agar plates [@bib12].

DNA extraction and identification of MRSA isolates {#sec2.3}
--------------------------------------------------

DNA extraction was performed by using the boiling method as described previously [@bib13]. All phenotypically identified methicillin-resistant isolates were confirmed by PCR for the presence of the *mecA* gene.

SCC*mec* typing {#sec2.4}
---------------

A multiplex PCR with four primer pairs was performed to identify the five main known SCC*mec* types [@bib14]. PCR was performed in a final volume of 25 μL containing 0.5 μM of each primer. The PCR protocol consisted of an initial denaturation step at 94°C for 4 minutes, then 30 amplification cycles at 94°C for 30 seconds, at 55°C for 30 seconds and at 72°C for 1 minute, followed by a final extension step at 72°C for 5 minutes. Amplified products were analysed by electrophoresis on 1% agarose gel containing safe stain.

*spa* typing {#sec2.5}
------------

*spa* typing was performed for MRSA isolates as described by Harmsen et al. [@bib15]. The amplified products were subjected to DNA sequencing by Bioneer (Seoul, South Korea). The obtained sequences were edited by Chromas 1.45 software (Technelysium, Tewantin, Australia; <http://technelysium.com.au/wp/chromaspro/>). The guidelines from the Ridom SpaServer database (<http://spaserver.ridom.de/>) were used to assign the edited sequences to particular *spa* types.

*agr* typing {#sec2.6}
------------

The *agr* types of all *S. aureus* isolates (MSSA and MRSA) were determined by the PCR method as described by Shopsin et al. [@bib16].

Results {#sec3}
=======

A total of 167 *S. aureus* strains were obtained in this study, of which 108 (64.7%) were found to be MRSA. The distribution of MRSA isolates among patients, HCWs and surfaces were 64.2% (*n* = 79), 50% (*n* = 7) and 73.3% (*n* = 22), respectively ([Table 1](#tbl1){ref-type="table"}). According to antibiotic susceptibility testing results, high rate of resistance to antibiotics such as cefoxitin (99%, *n* = 107), penicillin (96%, *n* = 104), norfloxacin (87%, *n* = 94), gentamicin (86%, *n* = 93), ampicillin (85%, *n* = 92), mupirocin and erythromycin (81%, *n* = 87), clindamycin (75%, *n* = 81) and rifampicin (65%, *n* = 70) was observed among MRSA strains. No resistance was observed for linezolid or tigecycline. The most frequent SCC*mec* type among 108 MRSA isolates was SCC*mec* type III (75%; *n* = 81), followed by type I (20.4%; *n* = 22) and type IV (1.8%; *n* = 2). The rest of the MRSA isolates (2.8%; *n* = 3) were nontypeable by this method. Also, by using the *agr* typing method, 78.4% (*n* = 131), 10.2% (*n* = 17) and 4.8% (*n* = 8) of isolates belonged to *agr* type I, II and III, respectively, and 6.6% of isolates (*n* = 11) were nontypeable. The results of SCC*mec* and *agr* typing are presented in [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}. *spa* types t030 and t037 were the first and second most predominant *spa* types in all patient, HCW and surface isolates, being found in 56.4% (*n* = 57) and 25.6% (*n* = 26) of isolates, respectively. Also, *spa* type t16471 was reported for the first time in the world in this study ([Table 4](#tbl4){ref-type="table"}). Distribution of molecular types and different resistant patterns in 101 MRSA isolates are shown in [Table 4](#tbl4){ref-type="table"} (seven isolates were not typed by *spa* typing).Table 1Frequency of MRSA and MSSA in patients, HCWs and surfaces in Shahid Motahari HospitalTable 1CharacteristicNo. of samplesMRSAMSSATotalPatients17579 (64.2)44 (35.8)123 (100)HCWs887 (50)7 (50)14 (100)Surfaces14222 (73.3)8 (26.7)30 (100)Total405108 (64.7)59 (35.3)167 (100)[^1][^2]Table 2Results of SCC*mec* typing among MRSA isolatesTable 2SCC*mec* typePatientHCWSurfaceTotalI16 (14.8)06 (5.6)22 (20.4)III58 (53.7)7 (6.5)16 (14.8)81 (75)IV2 (1.8)002 (1.8)Nontypeable3 (2.8)003 (2.8)Total79 (73.1)7 (6.5)22 (20.4)108 (100)[^3][^4]Table 3Genotyping of *Staphylococcus aureus* isolates by *agr* typing methodTable 3*agr* typePatientHCWSurfaceTotalI94 (56.3)13 (7.8)24 (14.3)131 (78.4)II11 (6.6)2 (1.2)4 (2.4)17 (10.2)III8 (4.8)008 (4.8)IV0000Negative10 (6)01 (0.6)11 (6.6)Total (%)123 (73.7)15 (9)29 (17.3)167 (100)[^5][^6]Table 4Distribution of molecular types and different antibiotic resistant patterns in 101 MRSA isolatesTable 4*spa* type (N; %)No. patientsNo. HCWsNo. surfacesSCC*mec* type*agr* typeResistance profileNo. isolatest030 (57; 56.4)40512III, IIGM, MUP, RP, E, CD, T, IM, PG, NOR48NOR2NOR, SXT, PG7t037 (26; 25.6)2312III, IIGM, NOR, SXT, CD, E, PG, IM16RP, MUP, GM, PG4PG, IM, T, CD, E6t046 (3; 3)300IIE, CD, T, PG, IM, GM, MUP, RP, NOR3t4864 (2; 2)200IIIIIIM, PG, SXT, NOR, E, T, GM2t091 (2; 2)200NT, IIIII, IE, CD, T, PG, GM, MUP, SXT2t789 (2; 2)200NT, IIIIC, PG, CD, E2t459 (1; 1), t16471 (1; 1)1, 00, 10, 0I, IIIIGM, MUP, RP, NOR, E, CD, T, PG, IM2t363 (1; 1)100IVIMUP, E, PG, IM1t3802 (1; 1), t304 (1; 1)1, 10, 00, 0NT, IIPG2t937 (1; 1)100IIIPG, IM1t230 (1; 1)100IVIMUP, PG, IM1t3132 (1; 1), t701 (1; 1)0, 10, 01, 0I, IIIII, IGM, MUP, NOR, E, CD, T, PG, IM2[^7]

Discussion {#sec4}
==========

Because of the damage to the first mechanical barrier of the skin, burn patients are more prone to be colonized by different microorganisms. Sepsis is the major complication in burns and is associated with a high rate of mortality in burn patients [@bib3]. Among different infection causing organisms, *S. aureus* and notably MRSA, is the major cause of HAIs as well as infections acquired from the community [@bib17]. Different studies in Iran have shown an increase in the prevalence of MRSA in the country [@bib18]. We found the prevalence of MRSA to be 64.7%, which is comparable to the results obtained by Namvar et al. [@bib18] (65%) and Emaneini et al. (63.6%) [@bib19]. This rate was higher than that reported by Darban-Sarokhalil et al. [@bib2] (35%) and less than that of Song et al. [@bib20] (98%). These discrepancies in the prevalence of MRSA among various studies might be due to the diverse antibiotic use patterns, different infection control policies and lack of supervision on antibiotic use in different centres. In this study, MRSA strains exhibited high rates of resistance to several antibiotics of different classes, notably mupirocin, which is the antibiotic of choice for the treatment of nasally carried staphylococcal infections.

*S. aureus* (MRSA) was found with high frequency in the hospital environment on different surfaces which can colonize the nares and hands of HCWs and therefore can be considered as an important source of dissemination to inpatients [@bib6], [@bib21]. Nowadays typing methods are considered as important tools to assess the prevalence and transmission origin of HAIs [@bib22]. In this study, we used three typing methods (SCC*mec, spa* and *agr* typing) to find the common lineages of *S. aureus* strains circulating in one burn hospital in Tehran. While SCC*mec* types I, II and III are known to be found among the hospital-acquired clones (HA-MRSA), types IV and V are mostly considered to be community acquired [@bib23], [@bib24]. In this study, SCC*mec* types III and I were the most prevalent SCC*mec* types among MRSA isolates (75% and 20.4%, respectively). It can be concluded from this prevalence that the patients we studied might have acquired the infection from the hospital environment and/or HCWs as SCC*mec* type III, is related to HA-MRSA isolates. In previous studies from Iran performed by Fatholahzadeh et al. [@bib25], Parhizgari et al. [@bib22], Bayat et al. [@bib26] and Namvar et al. [@bib18], SCC*mec* type III was found among 98%, 97.5%, 82% and 56.8% of MRSA strains, respectively. Similarly, Chen et al. [@bib27] and Rodrigues et al. [@bib28] reported SCC*mec* type III to be the dominant type among colonizers of burn patients.

In this study, 15 different *spa* types were found, among which t030 (56.4%) and t037 (25.6%) were the predominant types. These results are in agreement with other studies from Iran and other Asian countries [@bib26]. In a study carried out in South Africa, t037 was reported as one of the most dominant *spa* types. However, Emaneini et al. [@bib29] reported types other than t030 and t037 as the dominant *spa* types. These discrepancies in prevalence among different studies may be attributed to differences in the type of sample or even the time of sampling and geographical areas. It seems that t037 has been replaced by t030 *spa* type in Iran\'s hospitals [@bib26], [@bib30]. In agreement with our study, several other studies have indicated that t030 and t037 types most commonly belonged to the SCC*mec* type III and were classified as HA-MRSA. Also, for the first time we found *spa* type t16471, which had not been reported to date in the world in an MRSA strain that had colonized the nose of a HCW. These findings raise serious concerns about the possible spread of MRSA from the hospital environment and HCWs to inpatients in Tehran\'s hospitals.

One of the crucial regulatory components of *S. aureus* involved in controlling the expression of bacterial virulence factors is accessory gene regulator (*agr*). So far, four *agr* types (I, II, III and IV) have been identified among *S. aureus* strains [@bib31]. In our study, among the 167 *S. aureus* isolates, the predominant *agr* type was type I, with a frequency of 78.4%. This result is consistent with that of studies performed by van Leeuwen et al. [@bib31] (71%), Peerayeh et al. [@bib32] (55.1%) and Indrawattana et al. [@bib33] (58.7%), who reported *agr* type I to be the most frequent *agr* type among *S. aureus* isolates. The prevalence of *agr* type I in our study was more than that reported by Shopsin et al. [@bib16] in America (30.8%) and Ayed et al. [@bib34] in Tunisia (15%). These dissimilarities may be related to the differences in patient samples as well as in geographic location. Also, because infection control policies might be periodically changing in a healthcare setting, various isolate types might be found during different periods of sample collection.

In summary, we used three different typing methods in order to find the most common lineages of *S. aureus* (MSSA and MRSA) circulating in the hospital and the origin of their spread to patients. According to SCC*mec* typing results, we found that MRSA isolated from patients, HCWs and environmental surfaces had the same genotype. The most prevalent genotypic background of the isolates was SCC*mec* type III/t030, t037/*agr* type I, which was found in high frequency in patient, surface and HCW isolates. Therefore, better hospital infection control policies as well as continuous epidemiologic surveillance studies are highly recommended to efficiently prevent the spread of bacteria to inpatients.
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[^1]: Data are presented as *n* (%).

[^2]: HCW, healthcare worker; MRSA, methicillin-resistant *Staphylococcus aureus*; MSSA, methicillin-susceptible *S. aureus.*

[^3]: Data are presented as *n* (%).

[^4]: HCW, healthcare worker; MRSA, methicillin-resistant *Staphylococcus aureus.*

[^5]: Data are presented as *n* (%).

[^6]: HCW, healthcare worker.

[^7]: C, chloramphenicol; CD, clindamycin; E, erythromycin; GM, gentamycin; IM, imipenem; MRSA, methicillin-resistant *Staphylococcus aureus*; MUP, mupirocin; NOR, norfloxacin; NT, nontypeable; PG, penicillin; RP, rifampicin; SXT, trimethoprim/sulfamethoxazole; T, tetracycline.
